Barely Significant

Excerpts

3,862 sentences · 1 filter applied

Notably, no significant differences were detected in protein levels of PPARγ and SREBP1 in the in vivo and in vitro models, although a decreasing trend in SREBP1 protein levels was noted in LsEVs-treated mice ( Figures 6b, c ). 3.6 LsEVs alleviate MAFLD by protecting gut barrier integrity Research has shown that the functionality of the intestinal barrier is impaired in both mice and individuals suffering from fatty liver disease.
Dupilumab demonstrated a −8.5-point reduction in Urticaria Activity Score over 7 days (UAS7) and a −4.2-point reduction in Itch Severity Score (ISS7) versus placebo in omalizumab-naïve patients; in omalizumab-intolerant or incomplete responders, only modest benefits were observed (UAS7 −5.8 points, borderline significance; ISS7 not significant) ( 4 ).